Johnson & Johnson vs Tata Consultancy Services Limited: Strategic Comparison
Key Differences at a Glance
| Field | Johnson & Johnson | Tata Consultancy Services Limited |
|---|---|---|
| Revenue | $94.2B | $30.0B |
| Founded | 1886 | 1968 |
| Employees | 140,800 | 593,798 |
| Market Cap | $612.8B | $82.8B |
| Headquarters | United States | India |
Quick Stats Comparison
| Metric | Johnson & Johnson | Tata Consultancy Services Limited |
|---|---|---|
| Revenue | $94.2B | $30.0B |
| Founded | 1886 | 1968 |
| Headquarters | New Brunswick, New Jersey | Mumbai, Maharashtra, India |
| Market Cap | $612.8B | $82.8B |
| Employees | 140,800 | 593,798 |
Johnson & Johnson Revenue vs Tata Consultancy Services Limited Revenue — Year by Year
| Year | Johnson & Johnson | Tata Consultancy Services Limited | Leader |
|---|---|---|---|
| 2026 | N/A | $30.0B | Tata Consultancy Services Limited |
| 2025 | $94.2B | $30.2B | Johnson & Johnson |
| 2024 | $88.8B | $29.1B | Johnson & Johnson |
| 2023 | $85.2B | N/A | Johnson & Johnson |
Business Model Breakdown
Overview: Johnson & Johnson vs Tata Consultancy Services Limited
This in-depth comparison examines Johnson & Johnson and Tata Consultancy Services Limited across revenue, market value, business model, competitive positioning, and long-term growth strategy. Whether you are researching Johnson & Johnson on its own, evaluating Tata Consultancy Services Limited, or weighing the two companies side by side, the breakdown below highlights where each company leads and where the gap between Johnson & Johnson and Tata Consultancy Services Limited is widest.
On the headline numbers, Johnson & Johnson reports annual revenue of $94.2B against $30.0B for Tata Consultancy Services Limited, while their respective market capitalizations stand at $612.8B and $82.8B. Johnson & Johnson is headquartered in United States and Tata Consultancy Services Limited operates from India, and those different home markets shape how each company competes.
Johnson & Johnson: Johnson & Johnson began as a medical-products company in the nineteenth century and became a diversified healthcare giant. After the Kenvue separation, it is a more focused healthcare company centered on medicine and medical technology.
Tata Consultancy Services Limited: TCS is the operating engine of Tata's technology reputation: a massive delivery organization that sells trust, process, engineering talent and industry knowledge to global enterprises.
Business Models: How Johnson & Johnson and Tata Consultancy Services Limited Make Money
Johnson & Johnson and Tata Consultancy Services Limited pursue distinct approaches to generating revenue, and understanding how each company operates is the foundation of any fair comparison between Johnson & Johnson and Tata Consultancy Services Limited.
Johnson & Johnson business model: Johnson & Johnson makes money by discovering, developing, manufacturing, and selling prescription medicines and medical technologies. Innovative Medicine sells therapies in oncology, immunology, neuroscience, pulmonary hypertension, infectious disease, and cardiovascular/metabolism. MedTech sells surgery, orthopaedics, cardiovascular, and vision products to hospitals, physicians, and healthcare systems.
Tata Consultancy Services Limited business model: TCS earns revenue through long-term enterprise technology contracts across application development, maintenance, cloud, consulting, business process services, engineering, platforms, AI and cybersecurity.
Competitive Advantage: Johnson & Johnson vs Tata Consultancy Services Limited
The durability of a company's moat often decides long-term winners. Here is how the competitive advantages of Johnson & Johnson stack up against those of Tata Consultancy Services Limited.
Johnson & Johnson competitive advantage: Johnson & Johnson's advantage comes from scale, R&D depth, global regulatory capability, major oncology and immunology franchises, MedTech breadth, and a large commercial infrastructure.
Tata Consultancy Services Limited competitive advantage: TCS' advantage is delivery scale, Tata trust, large-account depth, industry domain expertise, training infrastructure, strong margins and a reputation for mission-critical execution.
Growth Strategy: Where Johnson & Johnson and Tata Consultancy Services Limited Are Headed
Future prospects matter as much as current results. The growth strategies below explain how Johnson & Johnson and Tata Consultancy Services Limited each plan to expand from here.
Johnson & Johnson growth strategy: The company is investing in oncology, immunology, neuroscience, cardiovascular MedTech, electrophysiology, surgery, R&D, acquisitions, and global commercial execution.
Tata Consultancy Services Limited growth strategy: TCS is growing through AI, cloud modernization, cybersecurity, data, engineering services, platforms, large transformation deals, partnerships and deeper penetration of existing enterprise accounts.
Financial Picture: Johnson & Johnson vs Tata Consultancy Services Limited
A closer look at the financial trajectory of Johnson & Johnson and Tata Consultancy Services Limited rounds out the comparison.
Johnson & Johnson: Johnson & Johnson's FY2025 sales increased 6.0% to $94.193 billion. Net earnings rose to $26.804 billion, helped by operating performance and other income items. Innovative Medicine generated $60.401 billion in sales, while MedTech generated $33.792 billion.
Tata Consultancy Services Limited: TCS reported FY2026 revenue of $30.017B, down 0.5% year over year in U.S. dollars, with FY2026 net margin of 19.8%. Q1 FY2027 revenue was $7.624B and TCV was $9.5B.
Company-Specific SWOT Notes
Johnson & Johnson
Johnson & Johnson's advantage comes from scale, R&D depth, global regulatory capability, major oncology and immunology franchises, MedTech breadth, and a large commercial infrastructure.
Johnson & Johnson wins through medical trust, R&D scale, global reach, leading drug franchises, MedTech breadth, and commercial execution.
The biggest risk is patent, pricing, litigation, or R&D pressure that weakens growth in key pharmaceutical and MedTech franchises.
The company is investing in oncology, immunology, neuroscience, cardiovascular MedTech, electrophysiology, surgery, R&D, acquisitions, and global commercial execution.
Tata Consultancy Services Limited
TCS has enormous delivery capacity, process maturity and large-client relationships across global enterprise technology.
Strong margins, cash generation and the Tata brand make TCS a trusted long-term partner for complex clients.
AI can automate parts of application maintenance and traditional services, pressuring pricing if TCS cannot move up the value chain.
Modernization, cybersecurity, cloud and enterprise AI create a new wave of transformation programs TCS can pursue.
Weak discretionary technology budgets or vendor consolidation can slow growth and pressure deal pricing.
Head-to-Head Scorecard
| Category | Winner | Why |
|---|---|---|
| Revenue Scale | Johnson & Johnson | Johnson & Johnson reports the larger revenue base ($94.2B), which serves as a core operational scale signal. |
| Profitability Potential | Comparable | Both organizations prioritize market penetration or are at equivalent reporting tiers. |
| Company Age | Johnson & Johnson | Founded in 1886 vs 1968. The earlier pioneer typically commands longer historical institutional legacy. |
| Innovation Moat | Tata Consultancy Services Limited | Higher aggregate count of major acquisitions and key R&D releases indicates a more active technology absorption velocity. |
| Scale (Employees) | Tata Consultancy Services Limited | A significantly larger reported workforce supports enhanced global distribution capability. |
| Market Cap | Johnson & Johnson | Higher public valuation denotes greater forward-looking investor conviction in earnings potential. |
| Future Outlook | Tied | Strategic auditing assesses that both maintain defensive leadership vectors within their core market clusters. |
Who Wins Each Category?
Johnson & Johnson reports the larger revenue base ($94.2B), which serves as a core operational scale signal.
Both organizations prioritize market penetration or are at equivalent reporting tiers.
Founded in 1886 vs 1968. The earlier pioneer typically commands longer historical institutional legacy.
Higher aggregate count of major acquisitions and key R&D releases indicates a more active technology absorption velocity.
A significantly larger reported workforce supports enhanced global distribution capability.
Who Wins: Johnson & Johnson or Tata Consultancy Services Limited?
Reviewed by Swet Parvadiya, May 2026 - Author Profile
Our analysts compile business strategy profiles from public financial filings, press releases, and analyst reports. Each profile is reviewed for accuracy before publication by our editorial desk and updated on a rolling basis.
Frequently Asked Questions: Johnson & Johnson vs Tata Consultancy Services Limited
Is Johnson & Johnson better than Tata Consultancy Services Limited?
Verdict: Between Johnson & Johnson and Tata Consultancy Services Limited, Johnson & Johnson is the stronger overall option based on higher annual revenue. The decision still depends on which factors matter most for your needs, but on the weight of the evidence above, Johnson & Johnson comes out ahead in this Johnson & Johnson vs Tata Consultancy Services Limited comparison.
Who earns more — Johnson & Johnson or Tata Consultancy Services Limited?
Johnson & Johnson earns more with $94.2B in annual revenue versus Tata Consultancy Services Limited's $30.0B. Johnson & Johnson leads on total revenue based on latest verified figures.
Which company has higher revenue — Johnson & Johnson or Tata Consultancy Services Limited?
Johnson & Johnson reported $94.2B, while Tata Consultancy Services Limited reported $30.0B. The revenue leader is Johnson & Johnson based on latest verified figures.
Johnson & Johnson revenue vs Tata Consultancy Services Limited revenue — which is higher?
Johnson & Johnson revenue: $94.2B. Tata Consultancy Services Limited revenue: $30.0B. Johnson & Johnson has the larger revenue base of the two companies.
Sources & References
- SEC EDGAR: Johnson & Johnson Annual Filings (10-K, 8-K)
- Johnson & Johnson Corporate Website
- Johnson & Johnson Annual Report 2025 - Revenue and Financial Data
- sec.gov
- Tata Consultancy Services Limited Corporate Website
- Tata Consultancy Services Limited Annual Report 2026 - Revenue and Financial Data
- tcs.com
- tcs.com
- tcs.com
- tata.com